Is the GLP-1 system a viable therapeutic target for weight reduction?
about
Expression and distribution of glucagon-like peptide-1 receptor mRNA, protein and binding in the male nonhuman primate (Macaca mulatta) brain.Weight loss effect of glucagon-like peptide-1 mimetics on obese/overweight adults without diabetes: A systematic review and meta-analysis of randomized controlled trials.Short-term exenatide treatment leads to significant weight loss in a subset of obese women without diabetes.Contribution of brown adipose tissue activity to the control of energy balance by GLP-1 receptor signalling in miceAt the centennial of Michaelis and Menten, competing Michaelis-Menten steps explain effect of GLP-1 on blood-brain transfer and metabolism of glucose.The incretin system ABCs in obesity and diabetes - novel therapeutic strategies for weight loss and beyond.
P2860
Is the GLP-1 system a viable therapeutic target for weight reduction?
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on September 2011
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Is the GLP-1 system a viable therapeutic target for weight reduction?
@en
Is the GLP-1 system a viable therapeutic target for weight reduction?
@nl
type
label
Is the GLP-1 system a viable therapeutic target for weight reduction?
@en
Is the GLP-1 system a viable therapeutic target for weight reduction?
@nl
prefLabel
Is the GLP-1 system a viable therapeutic target for weight reduction?
@en
Is the GLP-1 system a viable therapeutic target for weight reduction?
@nl
P2860
P1476
Is the GLP-1 system a viable therapeutic target for weight reduction?
@en
P2093
Darleen A Sandoval
Jenny Tong
P2860
P2888
P304
P356
10.1007/S11154-011-9170-8
P577
2011-09-01T00:00:00Z